@article{0ba8d1f91f3c4e15855574eb0f6f73a9,
title = "Replication-competent retroviruses in gene-modified T cells used in clinical trials: Is it time to revise the testing requirements?",
author = "Bear, \{Adham S.\} and Morgan, \{Richard A.\} and Kenneth Cornetta and June, \{Carl H.\} and Gwendolyn Binder-Scholl and Dudley, \{Mark E.\} and Feldman, \{Steven A.\} and Rosenberg, \{Steven A.\} and Shurtleff, \{Sheila A.\} and Rooney, \{Cliona M.\} and Helen Heslop and Gianpietro Dotti",
note = "Funding Information: This work was supported in part by grants from the Leukemia and Lymphoma Society Specialized Center of Research (SCOR; grant 7018), the National Institutes of Health (NIH) (3P50CA126752, P01CA094237, and 5U54HL081007), and the National Center for Research Resources/NIH National Gene Vector Biorepository program (P40 RR024928). The authors declared no conflict of interest.",
year = "2012",
month = feb,
doi = "10.1038/mt.2011.288",
language = "English (US)",
volume = "20",
pages = "246--249",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Cell Press",
number = "2",
}